Sustained Release Olanzapine

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43MH068925-01A1
Agency Tracking Number: MH068925
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solitcitation Year: 2004
Solitcitation Topic Code: N/A
Solitcitation Number: PHS2004-2
Small Business Information
AURITEC PHARMACEUTICALS, INC.
AURITEC PHARMACEUTICALS, INC., 2275 E FOOTHILL BLVD, PASADENA, CA, 91107
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 THOMAS Smith
 (617) 461-6263
 TSMITH@AURITECPHARMA.COM
Business Contact
Phone: (626) 376-4070
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The long-term goal of this research is to minimize morbidity associated with psychotic disorders by developing injectable long-acting formulations of olanzapine (Zyprexa/R), currently a leading atypical antipsychotic a

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government